Advanced Oncotherapy Share Forecast, Price & News

Wall Street analysts have given Advanced Oncotherapy a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Advanced Oncotherapy wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Advanced Oncotherapy is scheduled to release its next quarterly earnings announcement on Monday, September 27th 2021.
View our earnings forecast for Advanced Oncotherapy.

Advanced Oncotherapy plc (LON:AVO) announced its earnings results on Monday, June, 29th. The company reported ($9.83) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($8.90) by $0.93.
View Advanced Oncotherapy's earnings history.

Advanced Oncotherapy's stock was trading at GBX 32.50 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, AVO shares have increased by 4.6% and is now trading at GBX 34.
View which stocks have been most impacted by COVID-19.

Some companies that are related to Advanced Oncotherapy include Viemed Healthcare (VMD), Avacta Group (AVCT), Creo Medical (CREO), Hamilton Thorne (HTL), Titan Medical (TMD), Medica Group (MGP), Viemed Healthcare (VMD), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Kromek Group (KMK), MRI Interventions (MRIC), Protech Home Medical (PTQ), Protech Home Medical (PHM), Helius Medical Technologies (HSM) and Intelligent Ultrasound Group (IUG).
View all of AVO's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Advanced Oncotherapy investors own include UK Oil & Gas (UKOG), Avesoro Resources (ASO), Oxford Biomedica (OXB), BMR Group (BMR), GW Pharmaceuticals (GWPH), Lancashire (LRE), Sirius Minerals (SXX), Renishaw (RSW), Scancell (SCLP) and Tullow Oil (TLW).

Advanced Oncotherapy trades on the London Stock Exchange (LON) under the ticker symbol "AVO."

Shares of AVO and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of AVO stock can currently be purchased for approximately GBX 34.

Advanced Oncotherapy has a market capitalization of £118.94 million.

Advanced Oncotherapy employs 129 workers across the globe.

The official website for Advanced Oncotherapy is www.advancedoncotherapy.com.

Advanced Oncotherapy is headquartered at Third Fl Clearwater HSE, 4-7 Manchester Street, LONDON, W1U 3AE, United Kingdom.

Advanced Oncotherapy's mailing address is Third Fl Clearwater HSE, 4-7 Manchester Street, LONDON, W1U 3AE, United Kingdom. The company can be reached via phone at +44-20-36178728.